You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
鷺燕醫藥(002788.SZ)明確2019年度配股數量 即每10股配售2股
格隆匯 12-11 19:27

格隆匯12月11日丨鷺燕醫藥(002788.SZ)公佈,公司2019年度配股公開發行證券的相關議案已經公司第四屆董事會第十五次會議、第四屆監事會第十二次會議以及2019年第2次臨時股東大會審議通過,目前正處於中國證監會審核過程中。

根據公司股東大會授權,並經與保薦機構協商,公司於2019年12月11日召開第四屆董事會第十七次會議、第四屆監事會第十四次會議,審議通過《關於明確公司2019年度配股公開發行證券股份數量的議案》,就公司2019年度配股公開發行證券事項進一步明確配股數量,具體如下:

此次配股擬以實施本次配股方案的股權登記日收市後的股份總數為基數,按照每10股配售2股的比例向全體股東配售。配售股份不足1股的,按中國證券登記結算有限責任公司深圳分公司的有關規定處理。若以公司截至2019年9月30日的股份總數326,830,440股為基數測算,此次配股發行的股份數量為65,366,088股。自配股股權登記日至此次配股實施前,若因公司送股、資本公積金轉增股本及其他原因導致公司股份總數變動,則配售股份數量按照變動後的股份總數進行相應調整。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account